Probing Amylin Fibrillation at an Early Stage Via a Tetracysteine-recognising Fluorophore

Overview

Journal Talanta

Publisher Elsevier

Specialty Chemistry

Date 2017 Jun 13

PMID 28602190

Authors

Shih-Ting Wang

Yiyang Lin

Chia-Chen Hsu

Nadav Amdursky

Christopher D Spicer

Molly M Stevens

Affiliations

Soon will be listed here.

Abstract

Amyloid fibrillation is a nucleation-dependent process known be involved in the development of more than 20 progressive and chronic diseases. The detection of amyloid formation at the nucleation stage can greatly advance early diagnoses and treatment of diseases. In this work, we developed a new assay for the early detection of amylin fibrillation using the biarsenical dye 4,5-bis(1,3,2-dithiarsolan-2-yl)fluorescein (FlAsH), which could recognise tetracysteine motifs and transform from non-fluorescent form into strongly fluorescent complexes. Due to the close proximity of two cysteine residues within the hydrophilic domain of amylin, a non-contiguous tetracysteine motif can form upon amylin dimerisation or oligomerisation, which can be recognised by FlAsH and emit strong fluorescence. This enables us to report the nucleation-growth process of amylin without modification of the protein sequence. We showed that the use of this assay not only allowed the tracking of initial nucleation events, but also enabled imaging of amyloid fibrils and investigation of the effects of amyloid inhibitor/modulator toward amylin fibrillation.

References

Wei L, Jiang P, Xu W, Li H, Zhang H, Yan L . The molecular basis of distinct aggregation pathways of islet amyloid polypeptide. J Biol Chem. 2010; 286(8):6291-300. PMC: 3057848. DOI: 10.1074/jbc.M110.166678. View

Lopes D, Meister A, Gohlke A, Hauser A, Blume A, Winter R . Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. Biophys J. 2007; 93(9):3132-41. PMC: 2025658. DOI: 10.1529/biophysj.107.110635. View

Gama C, Tully S, Sotogaku N, Clark P, Rawat M, Vaidehi N . Sulfation patterns of glycosaminoglycans encode molecular recognition and activity. Nat Chem Biol. 2006; 2(9):467-73. DOI: 10.1038/nchembio810. View

Forbes J, Cooper M . Mechanisms of diabetic complications. Physiol Rev. 2013; 93(1):137-88. DOI: 10.1152/physrev.00045.2011. View

Huang T, Yang D, Plaskos N, Go S, Yip C, Fraser P . Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide. J Mol Biol. 2000; 297(1):73-87. DOI: 10.1006/jmbi.2000.3559. View

Linse S, Cabaleiro-Lago C, Xue W, Lynch I, Lindman S, Thulin E . Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A. 2007; 104(21):8691-6. PMC: 1866183. DOI: 10.1073/pnas.0701250104. View

LeVine 3rd H . Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993; 2(3):404-10. PMC: 2142377. DOI: 10.1002/pro.5560020312. View

Bernstein S, Dupuis N, Lazo N, Wyttenbach T, Condron M, Bitan G . Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat Chem. 2010; 1(4):326-31. PMC: 2918915. DOI: 10.1038/nchem.247. View

Chen Y, Glabe C . Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42. J Biol Chem. 2006; 281(34):24414-22. DOI: 10.1074/jbc.M602363200. View

10.

Kim Y, Park J, Lee H, Nam J . How Do the Size, Charge and Shape of Nanoparticles Affect Amyloid β Aggregation on Brain Lipid Bilayer?. Sci Rep. 2016; 6:19548. PMC: 4726094. DOI: 10.1038/srep19548. View

11.

Makin O, Serpell L . Structural characterisation of islet amyloid polypeptide fibrils. J Mol Biol. 2004; 335(5):1279-88. DOI: 10.1016/j.jmb.2003.11.048. View

12.

Westermark P, Engstrom U, Johnson K, Westermark G, Betsholtz C . Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A. 1990; 87(13):5036-40. PMC: 54256. DOI: 10.1073/pnas.87.13.5036. View

13.

Pallitto M, Murphy R . A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys J. 2001; 81(3):1805-22. PMC: 1301655. DOI: 10.1016/S0006-3495(01)75831-6. View

14.

Hawe A, Sutter M, Jiskoot W . Extrinsic fluorescent dyes as tools for protein characterization. Pharm Res. 2008; 25(7):1487-99. PMC: 2440933. DOI: 10.1007/s11095-007-9516-9. View

15.

Suk J, Zhang F, Balch W, Linhardt R, Kelly J . Heparin accelerates gelsolin amyloidogenesis. Biochemistry. 2006; 45(7):2234-42. PMC: 2657342. DOI: 10.1021/bi0519295. View

16.

Shankar G, Li S, Mehta T, Garcia-Munoz A, Shepardson N, Smith I . Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med. 2008; 14(8):837-42. PMC: 2772133. DOI: 10.1038/nm1782. View

17.

Mishra R, Sjolander D, Hammarstrom P . Spectroscopic characterization of diverse amyloid fibrils in vitro by the fluorescent dye Nile red. Mol Biosyst. 2011; 7(4):1232-40. DOI: 10.1039/c0mb00236d. View

18.

Griffin B, Adams S, Tsien R . Specific covalent labeling of recombinant protein molecules inside live cells. Science. 1998; 281(5374):269-72. DOI: 10.1126/science.281.5374.269. View

19.

Kayed R, Head E, Thompson J, McIntire T, Milton S, Cotman C . Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003; 300(5618):486-9. DOI: 10.1126/science.1079469. View

20.

Frederickson R, Brunden K . Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. J Biol Chem. 1995; 270(31):18666-71. DOI: 10.1074/jbc.270.31.18666. View